4D Molecular Therapeutics Inc Sustainability Reports
The company operates as a late-stage clinical biotechnology enterprise focusing on targeted and durable gene therapies. It invents and designs therapeutic vectors to address major genetic and medical conditions, primarily in ophthalmology and pulmonology.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
4 reports from 2021 to 2024
Company Profile
The company operates as a late-stage clinical biotechnology enterprise focusing on targeted and durable gene therapies. It invents and designs therapeutic vectors to address major genetic and medical conditions, primarily in ophthalmology and pulmonology.
Reports
4 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
